Richard Bartram

Chief Financial Officer, Esperion Therapeutics.

Companies

MBX Biosciences, Inc.Chief financial officer Sep 12, 2024 to Mar 18, 2026¹
Esperion TherapeuticsChief financial officer Dec 14, 2017 to Mar 16, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

MBX Biosciences, Inc. MBX15,000 shares³$760.6K at $50.71Feb 2, 2026
Esperion Therapeutics ESPR82,751 shares⁴Mar 14, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 2, 2026Granted 15,000 shares of MBX Biosciences, Inc.³
Mar 14, 2022Granted 37,000 shares of Esperion Therapeutics⁴
Oct 29, 2021Granted 18,700 shares of Esperion Therapeutics⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMBX Biosciences, Inc., Chief financial officer
2
SEC EDGAREsperion Therapeutics, Chief financial officer
3
SEC EDGARMBX Biosciences, Inc. shares after the filing of Feb 2, 2026
4
SEC EDGAREsperion Therapeutics shares after the filing of Mar 14, 2022
5
SEC EDGARForm 4 filed Nov 1, 2021